10-gingerol showed selective cytotoxicity against malignant T4-2 breast cancer cells, and could revert the malignant phenotype.
[10]-Gingerol Reverts Malignant Phenotype of Breast Cancer Cells in 3D Culture.
AI Summary
Key Findings
Abstract
Breast cancer is a complex and multifactorial disease. Tumors have a heterogeneous microenvironment, which have multiple interactions with other cell types, greatly influencing the behavior of tumor cells and response to therapy. The 3D culture mimics the microenvironment better found in vivo and is more appropriated than the traditional 2D culture made from plastic to test the cellular response to drugs. To investigate the effects of [10]-gingerol on breast tumor cells, we used physiologically relevant three-dimensional (3D) cultures of malignant and non-malignant human breast cells grown in laminin-rich extracellular matrix gels (lr-ECM). Our results showed selective cytotoxicity of [10]-gingerol against the malignant T4-2 breast cancer cell line compared to non-malignant S1 cells. The compound reverted the malignant phenotype of the cancer cells, downregulating the expression of Epidermal Growth Factor Receptor (EGFR) andβ1-integrin. Moreover, [10]-gingerol induced apoptosis in this cell line. These results suggest that [10]-gingerol may be an effective compound to use as adjuvant therapy in breast cancer treatment. This article is protected by copyright. All rights reserved.
Affiliation
Angelina M Fuzer
External References
- PubMed ID:
- 28112417
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.